4.5 Article

Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia

Related references

Note: Only part of the references are listed.
Article Oncology

PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia

Jianping Li et al.

Summary: Mutations in the NSD2 histone methyltransferase (p.E1099K) were found to drive the relapse of pediatric acute lymphoblastic leukemia (ALL). These NSD2-mutant cells exhibited resistance to glucocorticoids, which was restored by correcting the mutation. The resistance was due to decreased expression of glucocorticoid receptor (GR) and the failure of glucocorticoids to activate GR expression. The use of PRC2 inhibitors reversed the glucocorticoid resistance by restoring GR levels and activation of proapoptotic genes, providing a potential therapeutic approach for relapsed ALL associated with NSD2 mutation.

CANCER DISCOVERY (2022)

Article Hematology

Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL

Koshi Akahane et al.

Summary: Asparaginase therapy is important for T-cell acute lymphoblastic leukemia (T-ALL) patients. The methylation status of the ASNS gene is associated with asparaginase sensitivity and prognosis in T-ALL.

BLOOD ADVANCES (2022)

Article Hematology

Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients

Jordy C. G. van der Zwet et al.

Summary: Recurrent inactivating aberrations of NR3C1 have been identified in 7% of pediatric T-cell ALL patients at diagnosis, especially in early thymic progenitor-ALL patients, contributing to steroid resistance. However, there is no correlation between NR3C1 messenger RNA expression and steroid response in primary diagnostic patient samples.

HEMASPHERE (2021)

Review Hematology

Pediatric acute lymphoblastic leukemia

Hiroto Inaba et al.

HAEMATOLOGICA (2020)

Article Biochemistry & Molecular Biology

Maftools: efficient and comprehensive analysis of somatic variants in cancer

Anand Mayakonda et al.

GENOME RESEARCH (2018)

Article Multidisciplinary Sciences

Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases

Jian-Feng Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Oncology

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia

Ling-Wen Ding et al.

CANCER RESEARCH (2017)

Article Genetics & Heredity

Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance

Geraldine Vitellius et al.

HUMAN MUTATION (2016)

Article Multidisciplinary Sciences

Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia

Koichi Oshima et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Biochemical Research Methods

PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels

Yongwook Choi et al.

BIOINFORMATICS (2015)

Article Biochemical Research Methods

circlize implements and enhances circular visualization in R

Zuguang Gu et al.

BIOINFORMATICS (2014)

Article Allergy

The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease

Robert H. Oakley et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Review Oncology

Relapsed childhood acute lymphoblastic leukaemia

Deepa Bhojwani et al.

LANCET ONCOLOGY (2013)

Article Genetics & Heredity

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

Jacob D. Jaffe et al.

NATURE GENETICS (2013)

Article Multidisciplinary Sciences

CREBBP mutations in relapsed acute lymphoblastic leukaemia

Charles G. Mullighan et al.

NATURE (2011)

Review Oncology

Glucocorticoid use in acute lymphoblastic leukaemia

Hiroto Inaba et al.

LANCET ONCOLOGY (2010)

Review Medicine, General & Internal

Drug therapy - Treatment of acute lymphoblastic leukemia

CH Pui et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)